Clinical trials to test convalescent plasma in hospital patients expanding
Two clinical trials launched in April to evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19 are expanding, the National Institutes of Health announced yesterday.
The trials each expect to enroll about 1,000 hospitalized patients at academic and community-based hospitals across the country, who will be randomly assigned to receive the treatment or a placebo. Both trials anticipate results as early as this fall.
Related News Articles
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Food and Drug Administration yesterday published an announcement from Otsuka ICU Medical saying that the company issued a voluntary recall for a mislabeled…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…